HealthLeaders Media47m
U.S. will pay Moderna $176M to develop an mRNA pandemic flu vaccine
The U.S. government will pay the vaccine maker Moderna $176 million to accelerate development of a pandemic influenza vaccine that could be used to treat bird flu in people, as concern grows about ...
As bird flu becomes a growing threat, Moderna is awarded $590M to develop mRNA pandemic influenza vaccines
Bird flu isn’t part of the “quad-demic” of viruses circulating through the country this winter—COVID, seasonal flu, ...
Moderna Is Getting $590 Million From the U.S. to Accelerate a Bird Flu Vaccine
The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.
Moderna awarded $590M to help accelerate development of mRNA-based bird flu vaccine: HHS
Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an mRNA-based bird flu vaccine, health officials said.
HealthDay on MSN6d
Moderna Receives $590M From HHS to Develop Bird Flu Vaccine
The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.
Moderna: The Good News Isn't Enough
Moderna is the only company in its peer group burning cash at an alarming rate. Click here to read more about MRNA stock and ...
Should we be worried about bird flu, the 'unpredictable shape-shifter?'
Bird flu has decimated poultry flocks and infected cattle herds. The risk to humans is currently low, but that could easily ...